Quipt Home Medical Corp. (QIPT)
USD 2.02
(-8.18%)
USD 2.02
(-8.18%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 81.73 Million USD | 352.95% |
| 2022 | 18.04 Million USD | 338.75% |
| 2021 | -7.55 Million USD | -20.74% |
| 2020 | -6.25 Million CAD | -165.15% |
| 2019 | 9.6 Million CAD | -25.96% |
| 2018 | 12.97 Million CAD | 27.59% |
| 2017 | 10.17 Million CAD | 74.08% |
| 2016 | 5.84 Million CAD | 118.21% |
| 2015 | -32.09 Million CAD | -183.95% |
| 2014 | -11.3 Million CAD | -321.65% |
| 2013 | -2.68 Million CAD | -1157.08% |
| 2012 | 253.55 Thousand CAD | 143.61% |
| 2011 | -581.47 Thousand CAD | 79.15% |
| 2010 | -2.78 Million CAD | -13228.18% |
| 2009 | -20.92 Thousand CAD | -103.63% |
| 2008 | 575.91 Thousand CAD | -38.01% |
| 2007 | 929.01 Thousand CAD | -16.14% |
| 2006 | 1.1 Million CAD | -5.5% |
| 2005 | 1.17 Million CAD | -11.88% |
| 2004 | 1.33 Million CAD | 1.06% |
| 2003 | 1.31 Million CAD | 120.41% |
| 2002 | 597.23 Thousand CAD | -16.67% |
| 2001 | 716.74 Thousand CAD | -14.55% |
| 2000 | 838.75 Thousand CAD | 12573.21% |
| 1999 | -6724.46 CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 78.48 Million USD | -4.02% |
| 2024 Q2 | 83.27 Million USD | 5.7% |
| 2024 Q3 | 84.24 Million USD | 2.07% |
| 2023 Q2 | 105.22 Million USD | 357.23% |
| 2023 Q1 | 23.01 Million USD | 27.54% |
| 2023 Q3 | 76.44 Million USD | -27.35% |
| 2023 Q4 | 81.73 Million USD | 6.92% |
| 2023 FY | 81.73 Million USD | 352.95% |
| 2022 FY | 18.04 Million USD | 338.75% |
| 2022 Q1 | -3.2 Million USD | 57.66% |
| 2022 Q4 | 18.04 Million USD | -1.08% |
| 2022 Q2 | 7.13 Million USD | 322.97% |
| 2022 Q3 | 18.24 Million USD | 155.67% |
| 2021 Q1 | 1.19 Million USD | 119.03% |
| 2021 FY | -7.55 Million USD | -20.74% |
| 2021 Q4 | -7.55 Million USD | -148.95% |
| 2021 Q3 | -3.03 Million USD | -197.78% |
| 2021 Q2 | 3.1 Million USD | 160.71% |
| 2020 Q4 | -6.25 Million CAD | 37.76% |
| 2020 FY | -6.25 Million CAD | -165.15% |
| 2020 Q3 | -10.05 Million CAD | -163.29% |
| 2020 Q1 | 16.99 Million CAD | 76.89% |
| 2020 Q2 | 15.89 Million CAD | -6.51% |
| 2019 Q2 | 5.14 Million CAD | -46.44% |
| 2019 Q3 | 16.02 Million CAD | 211.62% |
| 2019 Q4 | 9.6 Million CAD | -40.03% |
| 2019 FY | 9.6 Million CAD | -25.96% |
| 2019 Q1 | 9.59 Million CAD | -26.03% |
| 2018 Q3 | 11.07 Million CAD | 2.32% |
| 2018 Q1 | 10.81 Million CAD | 6.34% |
| 2018 FY | 12.97 Million CAD | 27.59% |
| 2018 Q2 | 10.82 Million CAD | 0.06% |
| 2018 Q4 | 12.97 Million CAD | 17.18% |
| 2017 Q1 | 7.42 Million CAD | 27.04% |
| 2017 Q4 | 10.17 Million CAD | 58.92% |
| 2017 Q3 | 6.4 Million CAD | 6.83% |
| 2017 Q2 | 5.99 Million CAD | -19.28% |
| 2017 FY | 10.17 Million CAD | 74.08% |
| 2016 Q1 | -6.52 Million CAD | 79.68% |
| 2016 Q3 | 5.82 Million CAD | 858.36% |
| 2016 Q4 | 5.84 Million CAD | 0.31% |
| 2016 FY | 5.84 Million CAD | 118.21% |
| 2016 Q2 | -768.08 Thousand CAD | 88.22% |
| 2015 Q3 | -62.22 Million CAD | -306.84% |
| 2015 Q4 | -32.09 Million CAD | 48.42% |
| 2015 Q2 | -15.29 Million CAD | -5.33% |
| 2015 FY | -32.09 Million CAD | -183.95% |
| 2015 Q1 | -14.51 Million CAD | -28.47% |
| 2014 Q2 | -6.01 Million CAD | 20.47% |
| 2014 Q3 | -2.33 Million CAD | 61.28% |
| 2014 Q4 | -11.3 Million CAD | -384.99% |
| 2014 Q1 | -7.56 Million CAD | -182.33% |
| 2014 FY | -11.3 Million CAD | -321.65% |
| 2013 FY | -2.68 Million CAD | -1157.08% |
| 2013 Q1 | 47.03 Thousand CAD | -81.45% |
| 2013 Q4 | -2.68 Million CAD | -312.96% |
| 2013 Q3 | -649.05 Thousand CAD | -359.69% |
| 2013 Q2 | 249.93 Thousand CAD | 431.43% |
| 2012 Q4 | 253.55 Thousand CAD | -7.12% |
| 2012 FY | 253.55 Thousand CAD | 143.61% |
| 2012 Q2 | -147.21 Thousand CAD | 82.77% |
| 2012 Q1 | -854.5 Thousand CAD | -46.95% |
| 2012 Q3 | 272.99 Thousand CAD | 285.44% |
| 2011 FY | -581.47 Thousand CAD | 79.15% |
| 2011 Q4 | -581.47 Thousand CAD | 54.27% |
| 2011 Q3 | -1.27 Million CAD | 28.62% |
| 2011 Q2 | -1.78 Million CAD | 22.17% |
| 2011 Q1 | -2.28 Million CAD | 17.93% |
| 2010 Q4 | -2.78 Million CAD | 0.0% |
| 2010 Q1 | 50.08 Thousand CAD | -35.55% |
| 2010 FY | -2.78 Million CAD | -13228.18% |
| 2010 Q2 | 101.85 Thousand CAD | 103.36% |
| 2009 Q2 | 312.32 Thousand CAD | 27.84% |
| 2009 Q3 | -20.92 Thousand CAD | -106.7% |
| 2009 Q1 | 244.3 Thousand CAD | -63.2% |
| 2009 Q4 | 77.71 Thousand CAD | 471.46% |
| 2009 FY | -20.92 Thousand CAD | -103.63% |
| 2008 Q4 | 663.83 Thousand CAD | 15.27% |
| 2008 Q1 | 954.48 Thousand CAD | -8.44% |
| 2008 Q3 | 575.91 Thousand CAD | -35.86% |
| 2008 Q2 | 897.84 Thousand CAD | -5.93% |
| 2008 FY | 575.91 Thousand CAD | -38.01% |
| 2007 Q2 | 831.98 Thousand CAD | 36.95% |
| 2007 Q1 | 607.49 Thousand CAD | 4.67% |
| 2007 Q4 | 1.04 Million CAD | 12.21% |
| 2007 FY | 929.01 Thousand CAD | -16.14% |
| 2007 Q3 | 929.01 Thousand CAD | 11.66% |
| 2006 Q1 | 1.31 Million CAD | 9.26% |
| 2006 Q4 | 580.37 Thousand CAD | -47.61% |
| 2006 FY | 1.1 Million CAD | -5.5% |
| 2006 Q2 | 1.26 Million CAD | -3.6% |
| 2006 Q3 | 1.1 Million CAD | -12.67% |
| 2005 FY | 1.17 Million CAD | -11.88% |
| 2005 Q1 | 1.39 Million CAD | 1.64% |
| 2005 Q2 | 2.11 Million CAD | 51.01% |
| 2005 Q4 | 1.2 Million CAD | 2.74% |
| 2005 Q3 | 1.17 Million CAD | -44.54% |
| 2004 Q4 | 1.37 Million CAD | 3.52% |
| 2004 Q1 | 1.46 Million CAD | 5.9% |
| 2004 FY | 1.33 Million CAD | 1.06% |
| 2004 Q2 | 2.7 Million CAD | 83.96% |
| 2004 Q3 | 1.33 Million CAD | -50.74% |
| 2003 Q3 | 1.31 Million CAD | 1.52% |
| 2003 Q2 | 1.29 Million CAD | 128.15% |
| 2003 FY | 1.31 Million CAD | 120.41% |
| 2003 Q1 | 568.35 Thousand CAD | -15.87% |
| 2003 Q4 | 1.38 Million CAD | 5.31% |
| 2002 Q1 | 729.5 Thousand CAD | -6.4% |
| 2002 FY | 597.23 Thousand CAD | -16.67% |
| 2002 Q4 | 675.55 Thousand CAD | 13.11% |
| 2002 Q3 | 597.23 Thousand CAD | -8.78% |
| 2002 Q2 | 654.71 Thousand CAD | -10.25% |
| 2001 FY | 716.74 Thousand CAD | -14.55% |
| 2001 Q4 | 779.35 Thousand CAD | 0.0% |
| 2000 FY | 838.75 Thousand CAD | 12573.21% |
| 1999 FY | -6724.46 CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -201.804% |
| BrainsWay Ltd. | -10.32 Million USD | 892.001% |
| Cerus Corporation | 84.35 Million USD | 3.103% |
| Envoy Medical, Inc. | -3.81 Million USD | 2243.013% |
| electroCore, Inc. | -9.95 Million USD | 921.04% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 1694.819% |
| IceCure Medical Ltd | -9.93 Million USD | 922.775% |
| Inogen, Inc. | -103.56 Million USD | 178.918% |
| OrthoPediatrics Corp. | -9.26 Million USD | 981.995% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 2344.837% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 724.069% |
| MaxCyte, Inc. | -27.76 Million USD | 394.401% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 1690.756% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 14295.76% |
| Orthofix Medical Inc. | 96.44 Million USD | 15.25% |
| PAVmed Inc | 29.08 Million USD | -181.01% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 582.523% |
| RxSight, Inc. | -6.68 Million USD | 1323.57% |
| Sight Sciences, Inc. | -102.71 Million USD | 179.574% |
| SI-BONE, Inc. | 5.72 Million USD | -1328.675% |
| TELA Bio, Inc. | -3.94 Million USD | 2169.752% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -42.591% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -23120.028% |
| Acutus Medical, Inc. | 12.27 Million USD | -565.645% |
| Talis Biomedical Corporation | -57.06 Million USD | 243.233% |
| Spectral AI, Inc. | -3.5 Million USD | 2434.604% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 270.184% |
| CVRx, Inc. | -59.95 Million USD | 236.324% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -4019.381% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -6297.318% |
| Bioventus Inc. | 372.51 Million USD | 78.059% |
| Venus Concept Inc. | 74.3 Million USD | -10.005% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 902.735% |
| LivaNova PLC | 62.53 Million USD | -30.708% |
| 908 Devices Inc. | -115.09 Million USD | 171.014% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 74.514% |
| Nemaura Medical Inc. | 9.92 Million USD | -723.52% |
| NeuroPace, Inc. | 54.33 Million USD | -50.421% |
| LENSAR, Inc. | -18.31 Million USD | 546.344% |
| Apyx Medical Corporation | -5.15 Million USD | 1686.77% |
| Cutera, Inc. | 288.3 Million USD | 71.649% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -987.618% |
| BioSig Technologies, Inc. | 262 Thousand USD | -31096.374% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 286.481% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 988.515% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 94.184% |
| Axonics, Inc. | -77.19 Million USD | 205.882% |
| Outset Medical, Inc. | 67.67 Million USD | -20.768% |
| IRIDEX Corporation | -4.28 Million USD | 2006.122% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 145.914% |
| IRadimed Corporation | -47.71 Million USD | 271.282% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 2801.074% |
| INVO Bioscience, Inc. | 8.45 Million USD | -867.142% |
| Telesis Bio, Inc. | 32.63 Million USD | -150.45% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 3366.594% |
| Varex Imaging Corporation | 316.9 Million USD | 74.208% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 3037.976% |
| Pulmonx Corporation | -42.36 Million USD | 292.952% |
| Dynatronics Corporation | 6.2 Million USD | -1217.441% |
| Modular Medical, Inc. | -8.04 Million USD | 1116.345% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 2002.129% |
| Semler Scientific, Inc. | -57.13 Million USD | 243.068% |
| InMode Ltd. | -135.39 Million USD | 160.368% |
| Bruker Corporation | 891.3 Million USD | 90.83% |
| Cytosorbents Corporation | 4.18 Million USD | -1854.429% |
| DexCom, Inc. | 2.02 Billion USD | 95.969% |
| Align Technology, Inc. | -840.47 Million USD | 109.725% |
| Viveve Medical, Inc. | -13.81 Million USD | 691.722% |
| ZimVie Inc. | 450.41 Million USD | 81.854% |
| Movano Inc. | -5.86 Million USD | 1493.36% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 160.789% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 14295.76% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -4019.381% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 77.092% |
| Profound Medical Corp. | -18.17 Million USD | 549.621% |
| Insulet Corporation | 798.1 Million USD | 89.759% |
| enVVeno Medical Corporation | -2.21 Million USD | 3785.054% |
| Surmodics, Inc. | -12.01 Million USD | 780.327% |
| iCAD, Inc. | -21.2 Million USD | 485.376% |
| Nuwellis, Inc. | -2.81 Million USD | 2999.415% |
| Biotricity, Inc. | 23.09 Million USD | -253.94% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 12.724% |
| Aethlon Medical, Inc. | -4.5 Million USD | 1915.652% |
| InspireMD, Inc. | -8.04 Million USD | 1115.966% |
| PAVmed Inc. | 29.08 Million USD | -181.01% |
| BIOLASE, Inc. | 11.34 Million USD | -620.509% |
| Beyond Air, Inc. | 6.22 Million USD | -1212.161% |
| FONAR Corporation | -14.66 Million USD | 657.332% |
| AxoGen, Inc. | 32.26 Million USD | -153.315% |
| Vivani Medical, Inc. | 42 Thousand USD | -194505.95% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 866.884% |
| Inari Medical, Inc. | -7.16 Million USD | 1241.384% |
| UFP Technologies, Inc. | 40.77 Million USD | -100.457% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -2563.555% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 1813.041% |
| Tenon Medical, Inc. | -1.25 Million USD | 6612.709% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 1174.606% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 785.329% |
| AdaptHealth Corp. | 2.21 Billion USD | 96.314% |
| Sintx Technologies, Inc. | 905 Thousand USD | -8931.436% |
| NanoVibronix, Inc. | -3.27 Million USD | 2593.426% |
| Quanterix Corporation | -132.95 Million USD | 161.474% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 3037.976% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 465.457% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 89.156% |
| TransMedics Group, Inc. | 121.13 Million USD | 32.526% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 412.202% |
| NeuroMetrix, Inc. | -1.49 Million USD | 5581.6% |
| Hyperfine, Inc. | -75.61 Million USD | 208.087% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 46.294% |
| Biomerica, Inc. | -3.38 Million USD | 2514.609% |
| Bone Biologics Corporation | -3.02 Million USD | 2800.566% |
| AVITA Medical, Inc. | -26.23 Million USD | 411.588% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 4545.932% |
| Silk Road Medical, Inc | 64.42 Million USD | -26.872% |